MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • MDS Virtual Congress 2020

    Non-Staged Bilateral GPi DBS Lead Revision Using iMRI: A Case Report

    B. Hwang, D. Mampre, K. Mills, A. Butala, W. Anderson (Baltimore, MD, USA)

    Objective: To demonstrate the feasibility of non-staged intraoperative MRI (iMRI) deep brain stimulation (DBS) lead revision under general anesthesia (GA). Background: DBS lead revision surgery…
  • MDS Virtual Congress 2020

    Refractory cervical dystonia: is the infiltration of the obliquus capitis inferior muscle a game changer?

    A. Beltrán, F. Rodríguez, J.L Chico García, P. Parra, I. Pareés, J.C Martínez Castrillo, A. Alonso Cánovas, G. Sánchez (Madrid, Spain)

    Objective: To communicate the results of infiltration of obliquus capitis inferior (OCI) muscle in complex cervical dystonia (CD). Background: Treatment of CD with botulinum toxin…
  • MDS Virtual Congress 2020

    Bilateral GPi DBS for the treatment of severe generalized genetic dystonia caused by KMT2B mutation (DYT-28)

    J. Lopez-Castellanos, M. Lotia (Little Rock, AR, USA)

    Objective: . Background: KMT2B-related dystonia (DYT-28) is a complex childhood-onset movement disorder, characterized by a limb onset dystonia progressing to generalized dystonia with cranio-cervical involvement…
  • 2019 International Congress

    Depression, Anxiety and Sleep Disturbances in Patients with Craniocervical Dystonias

    Z. Khayatova, Z. Zalyalova (Kazan, Russian Federation)

    Objective: This study aimed to examine whether botulinum neurotoxin (BT) treatment affects nonmotor symptoms of dystonia, particularly depression (D), anxiety (A) and sleep disturbances (SD)…
  • 2019 International Congress

    Knowledge, Attitude and Practices about Movement Disorders in India

    B. Shetty, S. Mittal, P. Kukkle (Bangalore, India)

    Objective: To understand the Knowledge about various Movement Disorders (MD) in general public and in various Movement Disorder Patients subgroups Background: The incidence of movement…
  • 2019 International Congress

    High dose off-label Safinamide treatment in Young Onset Parkinson’s Disease patients

    C. Carrarini, M. Russo, F. Barbone, F. Dono, M. Rispoli, M. Onofrj, A. Thomas (Chieti, Italy)

    Objective: To assess tolerability and efficacy of high dose Safinamide treatment in Young Onset Parkinson’s Disease (YOPD) patients with dystonia and history of impulse controls…
  • 2019 International Congress

    Interleaving stimulation mode can improve better the health-related quality of life in primary generalized or segmental dystonia than standard bilateral pallidal deep brain stimulation

    N. Kovács, A. Juhasz, D. Pintér, M. Harmat, I. Balás, J. Janszky (Pécs, Hungary)

    Objective: To compare the efficacy of standard and interleaving stimulation modes in the bilateral pallidal stimulation treatment of generalized and segmental primary dystonia. Background: For…
  • 2019 International Congress

    Directional stimulation for Dystonic tremor

    I. Aviles-Olmos, M. Alegre, J. Artieda, J. Guridi, M. Rodriguez-Oroz (Pamplona, Spain)

    Objective: Is our aim to present our experience with bilateral directional thalamic DBS for DT. Background: Dystonic tremor(DT) is characterized by coexisting tremor and abnormal…
  • 2019 International Congress

    High Dose Botulinum Toxin Therapy: Safety, Benefit and Endurance of Efficacy

    S. Chiu, B. Patel, M. Burns, J. Legacy, A. Shukla, A. Ramirez-Zamora, W. Deeb, I. Malaty (Gainesville, FL, USA)

    Objective: To assess safety, therapeutic response and long-term benefit of higher dose Onabotulinum toxin A (OnaA). Background: Botulinum toxin therapy is a powerful tool for…
  • 2019 International Congress

    Bilateral Globus pallidus interna Deep Brain Stimulation in Cranio-Cervical Dystonia (Meige syndrome) patient in Hong Kong

    C. Lau, C. Zhu, D. Chan, K. Ma, L. Au, A. Chan, R. Wong, J. Yeung, W. Poon, V. Mok (Hong Kong, Hong Kong)

    Objective: To report the first cranio- cervical dystonia (Meige syndrome) patient who received Deep Brain Stimulation (DBS) implant in Hong Kong. Background: Meige syndrome is…
  • « Previous Page
  • 1
  • …
  • 21
  • 22
  • 23
  • 24
  • 25
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley